Market Movers
Pre-Market and After Hours Market Movers
-
Paramount’s $108B Cash Bid for Warner Bros. Raises the Stakes as Fight With Netflix Enters New Phase
A high-stakes bidding war for Warner Bros was raised even further after Paramount Skydance unveiled a sweeping $108.4 billion all-cash…
Read More » -
Stock Market Today: Dow, S&P 500, Nasdaq Slip as Investors Brace for Major Fed Rate Decision
US stocks fell on Monday as Wall Street entered a pivotal week dominated largely by expectations for a Federal Reserve…
Read More » -
Stock Market Today: Dow, S&P 500, Nasdaq Waver as Wall Street Leans Into Rate-Cut Expectations
US stocks were mixed on Thursday as Wall Street digested fresh labor-market data and renewed hopes that the Federal Reserve…
Read More » -
Bitcoin Breaks Above $92,000 as Optimism Builds for a Possible December Rebound
Bitcoin rose back above $92,000 on Wednesday, breaking through a level closely watched by traders and renewing talk of a…
Read More » -
Stock Market Today: Dow Climbs as Weak ADP Jobs Data Fuels Fed Cut Hopes, Tech Slips on AI Worries
US stocks traded slightly higher on Wednesday as investors weighed a surprisingly soft private payrolls report against growing doubts about…
Read More » -
Amazon Debuts New AI Chip as Big Tech Races to Challenge Nvidia’s Dominance
Amazon introduced its newest AI chip on Tuesday, escalating a rapidly intensifying competition among tech giants vying to unseat Nvidia.
Read More » -
Dow, S&P 500, Nasdaq Edge Higher as Wall Street Stabilizes and Bitcoin Slips
US stocks were steadier on Tuesday, extending a tentative rebound after a shaky start to December that saw equities and…
Read More » -
Veolia Just Dropped $3 Billion on This Small-Cap Sleeper — Here’s Why That Matters
Enviri is selling its Clean Earth unit to Veolia for $3B—an 18× EBITDA deal that gives Veolia major U.S. scale…
Read More » -
Gibraltar’s $1.34 Billion Play To Dominate Roofing Could Be A Game-Changer!
Gibraltar’s $1.34B plan to acquire OmniMax International boosts its reach in roofing and rainwear, doubling product revenue and promising fast…
Read More » -
Zymeworks Stock Skyrockets After Cancer Breakthrough — But What’s Next?
Zymeworks soared 34% after its partnered drug Ziihera posted strong Phase 3 data, with Jazz Pharmaceuticals showing it improved outcomes…
Read More »
